The Carlyle Group and fellow PEU GTCR struck a $922 million deal to buy AMRI, Albany Molecular Research. Carlyle's latest deal in the pharmacy research space comes after The Carlyle Group sold PPD to Carlyle for $9.05 billion. Carlyle paid $3.6 billion to buy PPD six years ago. How many clinical research organizations can a PEU own and how many times?
I'll peruse the SEC filing on the deal for specifics and post any findings.
Update 6-11-17: Carlyle inked a deal to buy iNova Pharma, another pharmaceutical company that can send business to PPD and AMRI.
